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Host cell factor-1 (HCF-1) is a metazoan transcrip-
tional coregulator essential for cell-cycle progres-
sion and cell proliferation. Current models suggest
a mechanism whereby HCF-1 functions as a direct
coregulator of E2F proteins, facilitating the expres-
sion of genes necessary for cell proliferation. In this
report, we show that HCF-1 recruitment to numerous
E2F-bound promoters is mediated by the concerted
action of zinc finger transcription factors THAP11
and ZNF143, rather than E2F proteins directly.
THAP11, ZNF143, and HCF-1 form amutually depen-
dent complex on chromatin, which is independent of
E2F occupancy. Disruption of the THAP11/ZNF143/
HCF-1 complex results in altered expression of cell-
cycle control genes and leads to reduced cell prolif-
eration, cell-cycle progression, and cell viability.
These data establish a model in which a THAP11/
ZNF143/HCF-1 complex is a critical component of
the transcriptional regulatory network governing
cell proliferation.
INTRODUCTION
Host cell factor-1 (HCF-1) is a ubiquitously expressed transcrip-
tional coregulator that has been identified in a variety of tran-
scriptional regulatory complexes. HCF-1 is believed to function
as a molecular scaffold, linking sequence-specific transcription
factors with enzymes capable of altering the posttranslational
modifications of histones and other chromatin-associated pro-
teins (Ajuh et al., 2000; Liang et al., 2009; Vogel and Kristie,
2006, 2013; Wysocka et al., 2003). The biological significance
of HCF-1-dependent gene expression is underscored by multi-
ple studies demonstrating that HCF-1 function is critical for cell
proliferation and cell-cycle progression (Julien and Herr, 2003;
Mangone et al., 2010; Reilly et al., 2002; Wysocka et al., 2001).
Evidence suggesting that HCF-1-regulated transcription con-Ctributes to cell proliferation was initially provided by Wysocka
et al., who showed that loss of HCF-1 chromatin association pre-
cedes growth arrest of temperature-sensitive tsBN67 hamster
cells, which contain a single proline-to-serine missensemutation
(HCF-1 P134S) previously known to disrupt HCF-1 association
with the VP16 viral transactivator (Goto et al., 1997; Wysocka
et al., 2001). Subsequent work from the same laboratory re-
vealed that the S phase defect in tsBN67 cells grown at the
nonpermissive temperature could be mitigated by inactivation
of the retinoblastoma tumor suppressor protein (RB1), leading
to the hypothesis that HCF-1 promotes cell proliferation by regu-
lating E2F cell-cycle control genes (Reilly et al., 2002; Tyagi et al.,
2007). E2F family members E2F1, E2F4, and E2F3a have been
shown to contain the tetrapeptide HCF-1 binding motif (HBM;
[E/D]HxY) and physically interact with HCF-1 (Knez et al., 2006;
Tyagi et al., 2007). E2F1 and E2F4 associate with HCF-1 in
HeLa cells, and HCF-1 chromatin occupancy at E2F-regulated
genes has been suggested to occur by E2F-mediated recruit-
ment of HCF-1 in a cell-cycle-dependent manner (Tyagi et al.,
2007).
Although the current model proposes that HCF-1 is a direct
transcriptional coregulator of E2F proteins, recent evidence sug-
gests that other sequence-specific transcription factors may
also play a role in HCF-1 recruitment at cell-cycle and growth
control genes. Yu et al. have demonstrated that a ternary com-
plex composed of Yin Yang 1 (YY1), HCF-1, and deubiquitinase
BRCA1-associated protein-1 (BAP1) regulates the expression of
cell growth and proliferation genes (Yu et al., 2010). Additionally,
work in our laboratory and by others has shown that the Than-
atos-associated protein (THAP) domain-containing family of
atypical zinc finger transcription factors constitutes a large group
of putative HCF-1-associated transcriptional regulators (Dejosez
et al., 2008, 2010; Mazars et al., 2010; Parker et al., 2012). Ma-
zars et al. have demonstrated that THAP1 recruits HCF-1 to
the RRM1 promoter during endothelial cell proliferation, and
both THAP1 and HCF-1 are necessary for RRM1 gene expres-
sion (Mazars et al., 2010). We have previously shown that
THAP11 is an HCF-1-dependent transcriptional regulator and
cell proliferation factor in human colon cancer cells (Parker
et al., 2012). Interestingly, we found that THAP11 is recruitedell Reports 9, 967–982, November 6, 2014 ª2014 The Authors 967
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with HCF-1 at E2F target genes RBL1 and CDC25A, but the
functional relevance of this observation remains unknown.
In this report, we provide evidence that HCF-1 recruitment to
numerous E2F-bound promoters is mediated not by E2F factors
directly, but instead by the joint occupancy of zinc finger tran-
scription factors THAP11 and ZNF143. We further show that
THAP11, ZNF143, and HCF-1 assemble into a complex on chro-
matin and that stable complex association with chromatin is
mutually dependent on all three factors. The expression of cell
proliferation and cell-cycle control genes is found to be at least
partially THAP11/ZNF143/HCF-1 complex dependent, and dis-
ruption of this complex results in altered cell-cycle progression
and reduced cell proliferation. The present study changes our
current view of the role of E2F proteins in HCF-1 recruitment
and demonstrates a mechanism of THAP11/ZNF143-mediated
HCF-1 recruitment to key cell-cycle progression genes.
RESULTS
HCF-1 Occupancy at E2F1-Bound Promoters Correlates
with THAP11 and ZNF143 Binding
Our previous characterization of THAP11 function in human co-
lon cancer cells unexpectedly revealed that THAP11 bound with
HCF-1 at RBL1 and CDC25A promoters (Parker et al., 2012).
HCF-1 recruitment to both RBL1 and CDC25A promoters has
been previously shown to function in both an E2F- and cell-cy-
cle-dependent manner (Tyagi et al., 2007). Nonetheless, we
speculated that THAP11 might also play a role in HCF-1 recruit-
ment at these and, perhaps, other E2F target gene promoters.
To explore this possibility, we analyzed ENCODE E2F1 chro-
matin occupancy data sets (Consortium, 2011) for the presence
of a previously determined THAP11 binding motif (Dejosez
et al., 2010). This analysis identified 1,702 promoter-proximal
candidate THAP11 binding sites located within 400 base pairs
of E2F1-bound regions. Comparison of these regions with
ENCODE transcription factor chromatin immunoprecipitation
sequencing (ChIP-seq) data revealed that these putative
THAP11 binding sites frequently lie within experimentally deter-
mined ZNF143-bound regions. Direct sequence comparison
further showed that the THAP11 binding motif is highly similar
to an extended ZNF143 binding motif (Myslinski et al., 2006;
Wang et al., 2012), suggesting THAP11 and ZNF143may occupy
similar DNA sequences. To test if THAP11 or ZNF143 occupy
chromatin with HCF-1 at these E2F1-bound promoters, we per-
formed chromatin immunoprecipitation for each factor in HeLa
cells and determined binding at 62 candidate THAP11/ZNF143
and E2F-bound promoters, as well as two negative control pro-
moters (HBB and CHRM1). We found that the chromatin occu-
pancy of HCF-1, THAP11, and ZNF143 at these regions wasFigure 1. HCF-1 Occupancy at E2F Target Genes Correlates with THA
(A) HCF-1, THAP11, ZNF143, and E2F1 chromatin occupancy determined by ChI
THAP11/ZNF143 binding motifs.
(B) Matrix of pairwise Pearson product-moment correlation coefficients from Ch
(C) Distribution of THAP11, HCF-1, ZNF143, and E2F1 on the promoter proxima
(D) Schematic illustrating the positions of promoter proximal ChIP amplicons (bla
ZNF143 and known E2F1 binding sites are indicated. First exons of the indicated
See also Figure S1.
Chighly correlated, with Pearson pairwise correlation coefficients
exceeding 0.90 (Figures 1A and 1B), whereas E2F1 binding
showed no correlation with either factor (r < 0.19). ChIP-scanning
assays performed to determine each factor’s promoter-proximal
positioning revealed that THAP11, HCF-1, and ZNF143 share a
nearly identical binding profile that was distinct from that of
E2F1 (Figure 1C). Moreover, the location of maximum ChIP
signal observed for THAP11, HCF-1, and ZNF143 at CDC25A,
CDC6, and MCM3 promoter-proximal regions corresponds
with a conserved THAP11/extended ZNF143 binding motif (Fig-
ure 1D). Similar results demonstrating that HCF-1 binding is
coincident with THAP11 and ZNF143 rather than E2F binding
were also obtained in T98G glioblastoma cells, suggesting these
findings are not cell type specific (Figure S1). Together, these
data suggest that at a subset of E2F target genes, THAP11,
and/or ZNF143 may directly recruit HCF-1 to chromatin.
THAP11, ZNF143, and HCF-1 Chromatin Occupancy
Are Interdependent
To test the possibility that THAP11 and/or ZNF143 is necessary
for HCF-1 recruitment, we next performed a series of ChIP as-
says examining occupancy of each factor at these 62 promoters
following THAP11, ZNF143, or HCF-1 knockdown in HeLa
cells. THAP11 knockdown resulted in a significant decrease of
both HCF-1 and ZNF143 chromatin occupancy (Figure 2A), but
depletion of THAP11 from chromatin was neither uniform nor
complete. Pairwise scatterplots of HCF-1 or ZNF143 chromatin
occupancy relative to THAP11 revealed good correlation be-
tween the extent of THAP11 depletion and corresponding loss
of HCF-1 and ZNF143 binding (Figure 2B). Importantly, neither
HCF-1 nor ZNF143 protein levels were changed in THAP11
knockdown cells (Figure 2C), suggesting that the decrease in
HCF-1 and ZNF143 chromatin occupancy results from their
altered recruitment to these promoters.
A similar set of experiments was performed to determine the
role of ZNF143 in THAP11 and HCF-1 recruitment. As shown in
Figure 2D, HeLa cells expressing ZNF143 short hairpin RNA
(shRNA) show a significant reduction in average recruitment of
ZNF143, THAP11, and HCF-1 at these 62 target genes. Similarly
to what was observed for THAP11, the amount of ZNF143 that
remained bound at these promoters was variable and ranged
from unchanged to less than 25% remaining (Figure 2E), despite
substantial depletion of ZNF143 protein (Figure 2F). Decreases in
THAP11 and HCF-1 promoter occupancy upon ZNF143 knock-
down closely paralleled that of ZNF143 (Figure 2E). Because
THAP11 and HCF-1 total protein amounts were unchanged
upon ZNF143 knockdown (Figure 2F), these results suggest
that ZNF143 contributes to both THAP11 and HCF-1 recruitment
to chromatin.P11 and ZNF143 Binding
P assay in HeLa cells at the indicated 62 E2F1 target genes containing putative
IP assays in (A).
l regions of E2F1 target genes determined by ChIP-scanning assays.
ck rectangles) analyzed in (C). The approximate locations of putative THAP11/
genes are denoted by blue rectangles.
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Figure 2. THAP11, HCF-1, and ZNF143 Chromatin Occupancy
Are Interdependent
THAP11, HCF-1, and ZNF143 chromatin occupancy was determined
at each of the 62 genes shown in Figure 1A in THAP11, HCF-1, or
ZNF143 knockdown HeLa cells.
(A) ChIP in HeLa cells expressing either control (shNS) or THAP11
(shTHAP11) shRNA.
(B) Scatterplots of HCF-1 (top panel) or ZNF143 (bottom panel) chro-
matin occupancy relative to THAP11 binding.
(C) Immunoblots of THAP11, HCF-1, and ZNF143 in THAP11 knock-
down HeLa cells.
(D) ChIP in HeLa cells expressing either control or ZNF143 shRNA.
(E) Scatterplots of HCF-1 (top panel) or THAP11 (bottom panel) chro-
matin occupancy relative to ZNF143 binding.
(F) Immunoblots of THAP11, HCF-1, and ZNF143 in ZNF143 knock-
down HeLa cells.
(G) ChIP in HeLa cells expressing control or HCF-1 shRNA.
(H) Scatterplots of THAP11 (top panel) or ZNF143 (bottom panel)
chromatin occupancy relative to HCF-1.
(I) Immunoblots of THAP11, HCF-1, and ZNF143 in HCF-1 knockdown
HeLa cells.
In (A), (B), (D), (E), (G), and (H), each point represents one of 62 genes
shown in Figure 1A. Values are expressed as percentage of recovery
relative to input. In (B), (E), and (H), values are expressed as percentage
of occupancy relative to control shRNA (shNS)-expressing cells.
Student’s t test p values and Pearson product-moment correlation
coefficient (r) values are indicated.
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We previously demonstrated that THAP11 not only recruits
but also requires HCF-1 for chromatin association (Parker
et al., 2012). To determine if ZNF143 chromatin association
has a similar dependence on HCF-1, we performed THAP11
and ZNF143 ChIP assays in HCF-1 knockdown cells. Confirm-
ing our previous observations, HCF-1 knockdown in HeLa cells
resulted in a robust decrease in THAP11 promoter occupancy
(Figure 2G). Unexpectedly, however, HCF-1 knockdown also
resulted in a significant decrease in ZNF143 binding (Figure 2G).
Unlike THAP11 and ZNF143 shRNAs, HCF-1 knockdown
resulted in at least a 50% reduction of occupancy at most pro-
moters examined (Figure 2H). Nevertheless, both THAP11 and
ZNF143 relative promoter occupancy showed a strong linear
relationship with remaining HCF-1 binding. Because neither
THAP11 nor ZNF143 protein levels were changed (Figure 2I),
these results likely suggest that HCF-1 is necessary for both
THAP11 and ZNF143 binding at these promoters. Collectively,
the results presented in Figure 2 indicate that THAP11 and
ZNF143 are critical mediators of HCF-1 occupancy at these
62 E2F1-bound promoters and further demonstrate that
THAP11, ZNF143, and HCF-1 chromatin binding are mutually
dependent.
THAP11, ZNF143, and HCF-1 Form a Complex
on Chromatin
The nearly identical promoter-proximal positioning (Figure 1C)
and interdependent chromatin association (Figure 2) observed
for THAP11, HCF-1, and ZNF143 could indicate formation of
a complex between these factors. To explore this possibility
further, a series of sequential chromatin immunoprecipitation
experiments (ChIP-reChIP) was performed to determine if
THAP11, HCF-1, and ZNF143 simultaneously co-occupy the
promoters of E2F target genes involved in cell proliferation
and cell-cycle progression. Consistent with this hypothesis,
we found that ZNF143 was robustly reChIP’ed at all THAP11-
bound promoters examined (Figure 3A). Similar results were
obtained when the order of antibodies was reversed (i.e.,
ZNF143 ChIP followed by THAP11 reChIP; Figure 3B) indi-
cating that THAP11 and ZNF143 indeed occupy these pro-
moters simultaneously. Sequential ChIP assays were next
used to determine if THAP11 and ZNF143 co-occupy these
promoters together with HCF-1. As shown in Figure 3C, HCF-
1-bound promoters were effectively reChIP’ed by either anti-
THAP11 or anti-ZNF143 antibodies, thus confirming that
THAP11, ZNF143, and HCF-1 likely bind these promoters as
a complex. The lack of reChIP signal observed for THAP11
and ZNF143 at RRM1 following HCF-1 ChIP (Figure 3C) is
consistent with previous reports from our laboratory and others
suggesting that HCF-1 recruitment to RRM1 is mediated not by
THAP11 but instead by THAP1 (Mazars et al., 2010; Parker
et al., 2012). This internal control not only confirms the fidelity
of the sequential ChIP assay but also suggests that ZNF143
co-occupancy is not broadly applicable to all THAP protein/
HCF-1 complexes.
Although these results strongly indicate the formation of a
THAP11/ZNF143/HCF-1 complex, it remains possible that the
observed THAP11 and ZNF143 chromatin co-occupancy may
result from separate protein-DNA interactions that are in-Cdiscernible by conventional chromatin immunoprecipitation.
To rule out this possibility, we performed THAP11 ChIP and
subjected the protein-G bead-bound immunoprecipitated ma-
terial to extensive Benzonase nuclease digestion followed by
several stringent washes to remove proteins bound exclusively
through protein-nucleic acid interactions. After formaldehyde
crosslinks were reversed, ZNF143 recovery was monitored by
western blot, whereas the effectiveness of DNA digestion was
determined by quantitative PCR of THAP11/ZNF143-bound
promoters. As shown in Figure 3D, THAP11 ChIP recovered a
significant fraction of chromatin-bound ZNF143, which was un-
affected by Benzonase treatment despite a near complete
digestion of THAP11-associated DNA (Figure 3E). Because
the quantitative PCR (qPCR) amplicons used to monitor Benzo-
nase digestion span only 70–150 bp and either flank or lie imme-
diately adjacent to the presumptive THAP11/extended ZNF143
binding sites, the above results suggest that THAP11, HCF-1,
and ZNF143 likely co-occupy these sites as a complex. To
determine whether this complex is formed exclusively on chro-
matin, we performed coimmunoprecipitations from soluble
nuclear extracts. As expected from previous studies, HCF-1
immunoprecipitation recovered a large amount of soluble
THAP11, whereas from the same material a smaller fraction of
ZNF143was also recovered (Figure 3F).We find that under iden-
tical conditions, THAP11 immunoprecipitation recovered less
albeit detectable ZNF143, indicating that THAP11 can interact
with both HCF-1 and ZNF143 in soluble nuclear extracts as
well as on chromatin.
E2F Binding Is Dispensable for HCF-1 Recruitment
to Chromatin
The finding that THAP11 and ZNF143 are necessary for HCF-1
recruitment to E2F target genes was somewhat surprising
because previous reports suggested that E2F proteins (E2F1,
E2F3a, and E2F4) directly recruit HCF-1 to chromatin (Tyagi
et al., 2007; Tyagi and Herr, 2009). To independently examine
the role of E2F binding activity in HCF-1 recruitment, we per-
formed HCF-1 ChIP in E2F1 knockdown HeLa cells. We find
that, under conditions where E2F1 protein and chromatin occu-
pancy are significantly depleted, HCF-1 recruitment at the same
loci is mostly unchanged (Figures 4A and 4B). E2F4 knockdown
similarly failed to disrupt HCF-1 promoter occupancy at proto-
typical E2F target genes RBL1, CDC25A, CDC6, and MCM3
(Figure S2A). Because remaining E2F members may compen-
sate for loss of individual E2F proteins (Kong et al., 2007), we
next used knockdown of the E2F obligate heterodimeric partner
DP1 to determine if E2F functional redundancy explains why
HCF-1 promoter occupancy is insensitive to knockdown of indi-
vidual E2Fs. We find that, whereas depletion of DP1 is sufficient
to simultaneously reduce both E2F1 and E2F3 binding at these
promoters, HCF-1 binding is largely unchanged (Figures 4C
and 4D), suggesting direct E2F-mediated recruitment may not
be the primary mechanism of HCF-1 occupancy at these E2F-
bound promoters after all. To confirm this finding, we generated
T98G cells containing a chromosomally integrated wild-type or
E2F binding site mutant RBL1 promoter construct (Figure 4E)
and monitored HCF-1 occupancy at these ectopic loci by
ChIP. The specific E2F binding site mutations employed hereell Reports 9, 967–982, November 6, 2014 ª2014 The Authors 971
Figure 3. THAP11, HCF-1, and ZNF143 Simultaneously Co-occupy Chromatin
(A) THAP11 ChIP (top panel) followed by ZNF143 or control IgG ReChIP (bottom panel).
(B) ZNF143 ChIP (top panel) followed by THAP11 or control IgG ReChIP (bottom panel).
(C) HCF-1 ChIP (top panel) followed by THAP11 ReChIP (middle panel) or ZNF143 ReChIP (bottom panel).
(D) ZNF143 coprecipitation with THAP11 in formaldehyde-crosslinked SW620 cells is Benzonase resistant. THAP11 ChIP-enriched material was treated with or
without Benzonase. Digested nucleic acids and any associated proteins were removed by extensive washing, and remaining ZNF143 was detected by
immunoblot. Input corresponds to 5% of starting material.
(E) Confirmation of Benzonase digestion to remove THAP11-associated DNA was determined by qPCR using primers corresponding to THAP11 binding sites at
indicated gene promoters.
(F) ZNF143 associates with both THAP11 and HCF-1 in soluble nuclear extracts. HCF-1 and THAP11 were immunoprecipitated from SW620 nuclear extracts and
coprecipitated ZNF143 was detected by immunoblot. In the top and middle panels, 10% of the immunoprecipitation was loaded for immunoblot. In the bottom
panel, 90% of the immunoprecipitation was analyzed.
In (A)–(C) and (E), values represent mean ± SD of duplicate qPCRs from a single experiment performed at least three times with similar results. ChIP values are
expressed as percentage of recovery relative to input. ReChIP values are expressed as percentage of recovery relative to the initial ChIP. qPCR amplicons below
the limit of reliable detection are indicated as N.D. (not detected).
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have been previously shown to eliminate E2F binding at the
endogenous Rbl1 promoter in both mouse embryonic stem
cells and fibroblasts (Burkhart et al., 2010). Likewise, we find
that E2F recruitment, as determined by DP1 ChIP, is reduced
to near-background levels at the mutant RBL1 promoter (Fig-
ure 4F, compare DP1 ChIP at promoter and luciferase). HCF-1
occupancy, however, was unperturbed by the E2F binding site
mutations (Figure 4F), further reinforcing the idea that HCF-1
promoter occupancy is independent from that of E2F proteins.
Although the above results demonstrate that E2F binding is
dispensable for HCF-1 recruitment at promoters also co-occu-
pied by THAP11 and ZNF143, E2Fs might still play an important
role in HCF-1 recruitment, especially at genes that lack THAP11
and ZNF143 occupancy. To test this hypothesis, we first deter-
mined HCF-1 occupancy on promoters of E2F target genes
without discernible THAP11/ZNF143 binding motifs near their
known E2F binding sites. In both T98G (Figure 4G, left panel)
and HeLa cells (data not shown), we find that HCF-1 recruitment
to THAP11/ZNF143-free MCM4 and PCNA promoters is mark-
edly lower than HCF-1 binding at the E2F/THAP11/ZNF143
co-occupied RBL1 promoter, despite comparable levels of
E2F occupancy. Similar results were found when HCF-1 recruit-
ment at the CDC25A promoter, bound by THAP11, ZNF143, and
E2F, was compared to HCF-1 binding at E2F-only promoters
E2F1, CCNA2, CCNE1, and CDK1 (Figure 4G, right panel). In
both instances, total E2F binding, as determined by DP1 ChIP,
was similar between THAP11/ZNF143-bound and -unbound
promoters, suggesting that E2F binding alone may be insuffi-
cient to mediate substantial HCF-1 recruitment.
The small amount of HCF-1 bound at these promoters pre-
cluded a more detailed investigation of whether HCF-1 recruit-
ment to THAP11/ZNF143-free promoters is dependent on
E2F1. To circumvent this issue, we used available ChIP-seq
data sets to identify a candidate set of promoters that were
enriched for HCF-1 and E2F1 but devoid of THAP11 and
ZNF143. Fourteen of these promoters were chosen at random
and validated by ChIP-qPCR to have virtually no detectable
THAP11 and ZNF143 binding (Figure S2B). Knockdown of
E2F1 in HeLa cells resulted in substantial depletion of E2F1
across all chosen THAP11/ZNF143-free promoters, yet no
change in HCF-1 occupancy was observed (Figure 4H). These
findings strongly suggest that HCF-1 recruitment at E2F target
genes is independent of E2F binding regardless of THAP11
and ZNF143 co-occupancy.
To extend the above observations to a genome-wide scale, we
analyzed previously published and publicly available ChIP-seq
data. Although no single data set covered all of the proteins of
interest, we chose data sets that were generated in the same
cell line (HeLa-S3). E2F1 ChIP-seq has been performed by the
ENCODE consortium (Consortium, 2011), whereas ChIP-seq
data for THAP11, ZNF143, and HCF-1 was recently published
by Michaud et al. (2013). In order to compare these data, we
used identical parameters to first align raw sequencing reads
from all data sets to the human hg19 reference genome and
then call peaks using HOMER ChIP-seq analysis software (see
Supplemental Experimental Procedures for details).
Proteins that are found on chromatin in a single complex and
are responsible for each other’s occupancy should have signifi-Ccant spatial overlap, as observed by ChIP scanning in Figure 1C.
To extend this observation to a genome-wide scale for ZNF143,
THAP11, and E2F1 in reference to HCF-1 binding, we analyzed
the distribution of HCF-1 ChIP-seq peaks relative to the three
transcription factors. For colocalized peaks (no more than 500
bases apart), E2F1 is found in the vicinity of more HCF-1 peaks
(2,019) than either ZNF143 (1,300) or THAP11 (471, Figure S3A).
However, at the genomic loci where these proteins are colocal-
ized, HCF-1 appears to bind very closely to THAP11 and ZNF143
binding sites (90% of peaks within 100 bases) but has a much
broader distribution relative to E2F1 (90% of peaks within 350
bases, Figure 5A). Because E2F1 and THAP11/ZNF143/HCF-1
data were generated by independent laboratories, we wondered
whether the difference in the HCF-1 relative distribution could be
attributed to variations between experiments. To this end, we
performed the same analysis on an additional ZNF143 data set
published by ENCODE (Figure S3B). Although we observed an
increased range of HCF-1 peak distances to ENCODE ZNF143
(90% of peaks within 200 bases), this distribution was still signif-
icantly narrower than that of ENCODE E2F1 peaks, suggesting
that the observed difference in relative HCF-1 distribution is un-
likely to be an experimental artifact.
Additionally, we analyzed the relationship of ChIP-seq tag
densities (corresponding to amount of chromatin occupancy)
between HCF-1 and the other proteins. Within a chromatin-
bound complex, it can be expected that the chromatin occu-
pancy of one protein should correlate with the occupancy of
proteins in the same complex. We have observed this phenom-
enon for THAP11, ZNF143, and HCF-1 but not E2F1 (Figures 1A,
2B, 2E, 2H, and 4A). Similarly, when ChIP-seq tag densities are
compared between these four proteins on a genome-wide scale,
we observe a much better pairwise correlation between HCF-1
and THAP11 (Figure 5B) or ZNF143 (Figure 5C) than we do be-
tween HCF-1 and E2F1 (Figure 5D). Relatively good correlation
(r = 0.67) is also observed between HCF-1 and ZNF143 peaks
derived from the ENCODE data set (Figure S3C).
We considered the possibility that the dominant role of
THAP11/ZNF143 in HCF-1 recruitment may obscure the effect
that E2F1 has on HCF-1 occupancy at some of these loci. This
could potentially explain the poor correlation observed for
E2F1 and HCF-1 chromatin occupancy when THAP11/ZNF143
co-occupied loci are included in the analysis. To overcome this
possible limitation, we focused on loci where E2F1 ChIP-seq
peaks were directly overlapping with HCF-1 (by at least 50%
of the peak width) and excluded E2F1-HCF-1 loci co-occupied
by THAP11 or ZNF143 (Figure S3D). Such filtering should in-
crease the likelihood of identifying E2F1-dependent HCF-1
recruitment to chromatin. Nevertheless, this restrictive subset
of E2F1 peaks still showed no increase in correlation with chro-
matin occupancy of HCF-1. The genome-wide data analysis
strongly supports our gene-specific observations (Figures 4G
and 4H) and suggests that THAP11 and ZNF143 but not E2F1
play a dominant role in HCF-1 recruitment to chromatin.
HCF-1 recruitment at several of the genes identified here has
been shown to occur in a cell-cycle-dependent manner (Tyagi
et al., 2007). To determine if THAP11 and ZNF143 contribute to
the cell-cycle-dependent recruitment of HCF-1 previously attrib-
uted to E2F proteins, we examined the occupancy of HCF-1,ell Reports 9, 967–982, November 6, 2014 ª2014 The Authors 973
Figure 4. E2F Binding Is Dispensable for HCF-1 Recruitment to Chromatin
(A) E2F1 and HCF-1 ChIP in HeLa cells expressing either control (shNS) or E2F1 (shE2F1) shRNA. Each point represents one of 62 genes shown in Figure 1A.
Student’s t test p values are indicated.
(B) Immunoblots from control and E2F1 knockdown cells shown in (A).
(C) HCF-1, DP1, E2F1, and E2F3 ChIP assays in HeLa cells expressing either control or DP1 shRNA.
(D) Immunoblots from control and DP1 knockdown cells shown in (C).
(legend continued on next page)
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THAP11, ZNF143, E2F1, and E2F4 by ChIP at RBL1, CDC25A,
CDC6, and MCM3 promoters in synchronized HeLa cells.
HeLa cells were enriched at prometaphase by sequential thymi-
dine and nocodazole treatments. Following release from noco-
dazole block, cells were collected every 1–2 hr. Progression
through mitosis into G1 and S phases was monitored by immu-
noblotting for histone H3 serine 10 phosphorylation (H3S10P)
and cyclin E1 (Figure 6A). THAP11, ZNF143, and HCF-1 asso-
ciate with E2F target promoters in early G1 (at approximately
2 hr after nocodazole release) and coincided with maximal
E2F4 recruitment (Figure 6B). Because E2F4 knockdown in
asynchronously growing HeLa cells failed to reduce HCF-1 oc-
cupancy at these promoters (Figure S2A), we suggest that
recruitment of HCF-1 in early G1 is likely to be mediated by
THAP11 and ZNF143. Additionally, whereas E2F4 binding
steadily decreases as cells progress through G1, THAP11,
ZNF143, and HCF-1 remained promoter bound with maximum
occupancy achieved prior to peak E2F1 binding (Figure 6B).
The remarkable similarity in the cell-cycle-dependent binding
profiles of THAP11, HCF-1, and ZNF143, in conjunction with
our ChIP data in knockdown cells, strongly suggests that
THAP11 and ZNF143 are the primary determinants of cell-cy-
cle-dependent HCF-1 recruitment at these promoters.
THAP11/ZNF143/HCF-1 Complex Regulates
Expression of Cell-Cycle Genes and Is Necessary
for Cell Proliferation
To determine if the promoters occupied by THAP11, ZNF143,
and HCF-1 are also regulated by this complex, we examined
the mRNA expression of THAP11/ZNF143/HCF-1 target genes
in HCF-1 knockdown HeLa cells. HCF-1 knockdown was used
to deplete the THAP11/ZNF143/HCF-1 complex from target
gene promoters because HCF-1 knockdown results in a greater
decrease in complex occupancy than knockdown of either
THAP11 or ZNF143 alone (Figure 2). HeLa cells expressing
HCF-1 shRNA were collected 4 days posttransduction and
used todetermine themRNAexpressionof 32genes that showed
the greatest change in complex occupancy following HCF-1
knockdown (Figure 2G). As shown in Figure 7A, HCF-1 knock-
down resulted in a significant change in the expression of 27
out of the 32 genes. Notable among the mRNAs downregulated
by HCF-1 knockdown are key genes involved in cell proliferation
(MAP3K10, FGFR1, ACLY), G1/S phase progression (CDC25A,
CDC6, MCM3, RBL1), and mitosis (BUB1B, BOD1, RANGAP1).
Similar results were obtained when the THAP11/ZNF143/HCF-
1 complex was disrupted by simultaneous small interfering
RNA (siRNA)-mediated knockdown of THAP11 and ZNF143 (Fig-
ures S4A andS4B), suggesting that these genes are indeed func-
tional targets of a THAP11/ZNF143/HCF-1 complex.(E) Schematic of the RBL1 promoter construct stably integrated in T98G cells. Nu
The putative THAP11/ZNF143 binding site and known E2F binding sites are ind
primers used to detect occupancy at the promoter or luciferase coding sequenc
(F) HCF-1 and DP1 binding in T98G cells at the chromosomally integrated RBL1
(G) THAP11, HCF-1, and DP1 occupancy at the indicated E2F binding site in T9
(H) E2F1 and HCF-1 ChIP in HeLa cells expressing either control (shNS) or E2F1
THAP11/ZNF143-bound (positive) or unbound (negative).
In (C) and (F)–(H), values represent mean ± SD of duplicate qPCRs from a single ex
CConsistent with HCF-1-dependent expression of cell prolifer-
ation and cell-cycle progression genes, we found that HCF-1
depletion resulted in an almost complete reduction in cell prolif-
eration (Figure 7B). Similar to our previous results in colon cancer
cells (Parker et al., 2012), we found that THAP11 knockdown also
decreases HeLa cell proliferation, albeit less than HCF-1 knock-
down (Figure 7B). Cell-cycle analysis revealed that HCF-1
knockdown results in an almost 2-fold increase in G2/M phase
HeLa cells (Figure 7C, top panels), which is consistent with pre-
vious reports suggesting a role for HCF-1 during cytokinesis (Ju-
lien and Herr, 2003, 2004; Reilly et al., 2002). Importantly, we
found that THAP11 knockdown recapitulates the G2/M cell-cy-
cle defect observed in HCF-1 knockdown HeLa cells (Figure 7C,
bottom panels) suggesting this phenotype may arise from
perturbation of the THAP11/ZNF143/HCF-1 complex. Surpris-
ingly, no accumulation of G1 phase HeLa cells was observed
after HCF-1 knockdown despite previous reports indicating
otherwise (Julien and Herr, 2003, 2004; Tyagi et al., 2007). How-
ever, HCF-1 knockdown did result in significant increases in G1
phase cells in both T98G glioblastoma and SW620 colon carci-
noma cells (Figure S4C), suggesting that the cell-cycle defects
resulting from HCF-1 depletion are context dependent. The
lack of G1/S arrest observed in HCF-1 knockdown HeLa cells
may stem from the expression of human papillomavirus (HPV)
E6 and E7 oncoproteins in these HPV18-positive cells. High-
risk HPV E6 targets p53 for proteasome-mediated degradation,
whereas E7 binds to and inactivates hypophosphorylated RB1
(Dyson et al., 1989, 1992; Mu¨nger et al., 1989; Scheffner et al.,
1990). The E7-mediated disruption of repressive RB1/E2F com-
plexes results in aberrant E2F target gene expression including
genes critical for G1/S phase progression (reviewed in Moody
and Laimins, 2010). Consistent with numerous previous studies
demonstrating a role for E6 and E7 expression in HeLa cell pro-
liferation (DeFilippis et al., 2003; Goodwin and DiMaio, 2000; Gu
et al., 2006; Hall and Alexander, 2003; Johung et al., 2007; Psyrri
et al., 2004; Tang et al., 2006), we find that knockdown of HPV18
E6/E7 mRNA (Figure 7D) alone is sufficient to result in a signifi-
cant G1/S arrest (Figure 7E). This result suggests that the role
of THAP11/ZNF143/HCF-1 in HeLa cell G1/S progression is
likely masked by the expression of HPV18 E6 and E7 in these
cells.
Because cell death is a frequent consequence of mitotic delay
(Neumann et al., 2010), we next measured apoptosis in HeLa
cells undergoing prolonged HCF-1 or THAP11 knockdown. At
4 days posttransduction, HCF-1 and THAP11 shRNA-express-
ing HeLa cells showed no change in viability: Annexin V positive,
propidium iodide (PI) positive, or Annexin V/PI double-posi-
tive cells were comparable in HCF-1, THAP11, and control
knockdown cells (Figure 7F, top panels). HCF-1 and THAP11mbers indicate position relative to the annotated RBL1 transcription start site.
icated by an oval and circles, respectively. The relative position of the qPCR
e is indicated by closed and open arrowheads, respectively.
wild-type (WT) and E2F binding site mutant promoters as determined by ChIP.
8G cells as determined by ChIP assays.
shRNAs. Binding was determined at E2F-bound promoters shown to be either
periment performed at least three times with similar results. See also Figure S2.
ell Reports 9, 967–982, November 6, 2014 ª2014 The Authors 975
Figure 5. THAP11 and ZNF143, but Not E2F1, Genome-wide Chro-
matin Occupancy Correlates with HCF-1 Binding
(A) For E2F1, THAP11, or ZNF143 ChIP-seq peaks within 500 bases of HCF-1
peaks, the absolute distances between peak centers are plotted as box-and-
whisker plots. Whiskers indicate bottom 10% and top 90% of the population.
(B–D) At colocalized regions, ChIP-seq tags for each protein were counted in
the 1,000 bp region surrounding the HCF-1 binding sites. The total number of
peak pairs (n) and Pearson product-moment correlation coefficient (r) are
indicated.
See also Figure S3.
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cant increase in both Annexin V positive and Annexin V/PI dou-
ble-positive cells (Figure 7F, middle panels). Two days later,
only 23%of HCF-1 knockdown cells and 42%of THAP11 knock-
down cells were viable (Annexin V and PI negative) compared to
86% viability for control knockdown cells (Figure 7F, bottom
panels). The larger decrease in cell viability observed in HCF-1
versus THAP11 knockdown (Figure 7F) likely explains the prolif-
eration difference observed in Figure 7B. Collectively, these data
suggest that a transcriptional regulatory complex consisting of
HCF-1, THAP11, and ZNF143 contributes to the expression of
genes critical for cell proliferation and cell-cycle progression.
DISCUSSION
HCF-1 is a well-studied transcriptional coregulator with impor-
tant functions in cell proliferation and cell-cycle progression. In
this work, we demonstrate that a complex composed of HCF-1
and zinc-finger transcription factors THAP11 and ZNF143 is
the predominant mechanism for HCF-1 recruitment at many
E2F-regulated promoters. Furthermore, we demonstrate that
THAP11/ZNF143/HCF-1 complex-dependent expression of
cell-cycle control genes is necessary for cell proliferation, cell-
cycle progression, and maintenance of cell viability. This work
significantly alters the current model of HCF-1-directed tran-
scription and also suggests that the THAP11/ZNF143/HCF-1
complex is a novel component of the transcriptional regulatory
network controlling cell proliferation.
The discovery that HCF-1 is recruited to E2F-target genes of-
fers an appealing explanation for its role in cell-cycle regulation.
The current model of HCF-1 recruitment at these promoters is
based on a previous investigation (Tyagi et al., 2007) that sug-
gests HCF-1 is a direct cofactor for E2F proteins, evidenced
by the finding that HCF-1 physically interacts with E2Fs and oc-
cupies the promoters of several E2F-regulated cell-cycle control
genes. We now make several key observations that alter this
model of E2F-dependent HCF-1 recruitment and suggest a pre-
viously unrecognized role for THAP11 and ZNF143 in HCF-1
recruitment to, and regulation of, E2F-target genes. First, we
find that the amount of HCF-1 bound at E2F1-occupied pro-
moters correlates with THAP11 and ZNF143 rather than E2F1.
Additionally, both the cell-cycle-dependent recruitment and
spatial distribution of promoter-bound HCF-1 are highly coinci-
dent with THAP11 and ZNF143 but not E2F1 occupancy, sug-
gesting that THAP11 and ZNF143 are likely the key determinants
of HCF-1 recruitment to these loci. Strongly supporting this hy-
pothesis is the finding that knockdown of either THAP11 or
ZNF143 is sufficient to significantly reduce HCF-1 recruitment
Figure 6. HCF-1 Cell-Cycle-Dependent Promoter Recruitment
Correlates with THAP11 and ZNF143 Occupancy
(A) Immunoblots from thymidine-nocodazole synchronized HeLa cells upon
nocodazole release.
(B) ChIP assays from synchronized HeLa cells in (A). ChIP signal is expressed
as a percentage of the maximum signal observed throughout the time course.
Values are from a single experiment performed at least three times with similar
results.
Cat E2F-bound promoters. The inability to release HCF-1 from
these promoters following E2F1, E2F4, or DP1 knockdown is a
key feature of this work and is an attempt to directly ascertain
the role of E2F proteins in HCF-1 recruitment at cell-cycle control
genes. Although these findings suggest that HCF-1 may not be a
direct E2F-recruited coregulator, multiple studies have nonethe-
less affirmed that E2F-dependent recruitment of chromatin
modifying activities such as CBP/p300, KAT2A/GCN5, KAT2B/
PCAF, and KAT5/TIP60 histone acetyltransferase complexes is
essential for expression of cell-cycle control genes (Brehm
et al., 1998; Litovchick et al., 2007; Louie et al., 2004; Magna-
ghi-Jaulin et al., 1998; Taubert et al., 2004). Accordingly, we sug-
gest that distinct THAP11/ZNF143/HCF-1 and E2F-recruited
transcriptional regulatory complexes may cooperate to control
the expression of genes necessary for cell proliferation.
The importance of THAP11 in HCF-1 recruitment to E2F-
regulated promoters is further strengthened by the similarity of
cell physiological response to the knockdown of these factors.
Under both THAP11 and HCF-1 knockdown conditions, we
observe a substantial G2/M arrest in HeLa cells, which likely
leads to the subsequent apoptosis observed in both cases.
Consistent with these results, HCF-1 depletion has been shown
to result in upregulated SETD8/KMT5A/PR-Set7 leading to aber-
rant mitotic histone H4K20monomethylation and corresponding
defects in mitosis and cytokinesis (Julien and Herr, 2004). In
addition to this mechanism, the data reported here suggest
that HCF-1 may also contribute to G2/M phase progression by
directly regulating genes involved in mitotic spindle formation.
The THAP11/ZNF143/HCF-1 complex occupies the promoters
of mitotic spindle assembly checkpoint genes BUB1B and
BUB3 (Lara-Gonzalez et al., 2012), the Ran GTPase activating
protein RANGAP1 (Joseph et al., 2004), the cohesion acetyl-
transferase ESCO2 (Whelan et al., 2012), and BOD1, a recently
identified kinetochore protein necessary for chromosome bio-
rientation (Porter et al., 2007, 2013). Depletion of HCF-1, or
THAP11 and ZNF143, was sufficient to reduce BUB1B, BOD1,
and RANGAP1 expression. ESCO2 expression has been previ-
ously shown to involve ZNF143 (Nishihara et al., 2010). Unlike
previous reports (Julien and Herr, 2003, 2004; Tyagi et al.,
2007), we did not observe an increase in G1 phase HeLa cell
population upon HCF-1 knockdown. However, based on
numerous published studies and our present observation, we
speculate that this discrepancy may manifest as the result of
RB1 inactivation by HPV18 E7 oncoprotein expressed in these
cells, which results in deregulated E2F-target gene expression
andG1 to S phase transition (Moody and Laimins, 2010). Consis-
tent with this possibility, we find that RB-intact T98G glioblas-
toma and SW620 colon carcinoma cells do arrest in G1 following
HCF-1 knockdown. Furthermore, we have previously shown thatell Reports 9, 967–982, November 6, 2014 ª2014 The Authors 977
(legend on next page)
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THAP11 is a cell proliferation factor in SW620 aswell as other co-
lon cancer cells (Parker et al., 2012) and HCF-1 depletion results
in significant proliferation defects in these cells as well (J.B.P.,
unpublished data).
Another feature of this work is the observation that THAP11,
ZNF143, and HCF-1 binding at promoters containing THAP11/
extended ZNF143 binding motifs is mutually dependent on all
three factors. The extended ZNF143 binding motif, also referred
to as Staf binding sequence 2 (SBS2), differs from the canonical
ZNF143 binding motif (SBS1) by the addition of a 50 ACTACA
submotif adjacent to the core TCCCA ZNF143 recognition
sequence (Myslinski et al., 2006). Although shown to be dis-
pensable for ZNF143 binding in vitro, the ACTACA submotif is
nonetheless functional, because mutation of this sequence
significantly blunts ESCO2 promoter-driven luciferase activity
(Nishihara et al., 2010). In this context, we speculate that the
ACTACA submotif may be a sequence specific binding site for
THAP11. Structure-function analyses have revealed that THAP
proteins bind specific DNA sequences through bipartite recogni-
tion of adjacent DNAmajor and minor grooves (Campagne et al.,
2010; Sabogal et al., 2010). However, THAP11 has been sug-
gested to be a relatively poor DNA binding protein due to its
uniquely shortened DNA minor groove binding loop 4 region
(Campagne et al., 2010; Gervais et al., 2013; Sabogal et al.,
2010). Because of this, we hypothesize that HCF-1 may serve
as a bridge between THAP11 and chromatin-bound ZNF143,
thereby enabling stable association of the THAP11-HCF-1 com-
plex to promoters. Consistent with this hypothesis are our results
and the recent observation that HCF-1 physically associates
with ZNF143 and occupies extended, rather than canonical,
ZNF143 binding sites (Michaud et al., 2013; Ngondo-Mbongo
et al., 2013). This model would explain HCF-1- and ZNF143-
dependent THAP11 recruitment and, because HCF-1 does not
bind DNA directly, also HCF-1’s requirement for THAP11 and
ZNF143. Less clear, however, is why ZNF143 binding is sensitive
to THAP11 and HCF-1 depletion.
Two recent genome-wide investigations have revealed that
THAP11, HCF-1, and ZNF143 have at least partially overlapping
cistromes (Michaud et al., 2013; Ngondo-Mbongo et al., 2013).
When interpreted in the context of our findings, we suggest
that these reports may be indicative of a more broadly relevant
THAP11/ZNF143/HCF-1 transcriptional regulatory complex.
We note, however, that this interpretation contrasts with the
model reported by Ngondo-Mbongo et al. (2013) who suggested
that THAP11 and ZNF143 occupancy ismutually exclusive. Their
conclusion is based in large part on the inability of recombinantFigure 7. THAP11/ZNF143/HCF-1-Dependent Gene Expression Contrib
(A) Quantitative RT-PCR-determined mRNA expression changes at THAP11/HC
control or HCF-1 shRNA. Values represent the mean ± SD of four independent e
(B) HeLa cells expressing the indicated shRNAwere plated in 96-well plates (5,000
every 24 hr for 4 days. Values represent the mean ± SD from two independent e
(C) Cell-cycle analysis of HeLa cells collected 4 days posttransduction with HCF
(D) Left: quantitative RT-PCR determined HPV18 E6/E7 transcript levels in HeLa c
E7 shRNAs. Values represent the mean ± SD of two independent experiments. R
(E) Cell-cycle analysis of E6/E7 knockdown HeLa cells in (D).
(F) HeLa cells expressing the indicated shRNA were collected at 4, 6, and, 8 days
flow cytometry.
See also Figure S4.
CTHAP11 and ZNF143 DNA binding domains to simultaneously
occupy an extended ZNF143 oligonucleotide probe in electro-
phoretic mobility shift assays (EMSAs). Because this assay uti-
lizes truncated proteins and is devoid of HCF-1, we suggest
that this result likely reflects a limitation of EMSA rather than a
misinterpretation of our sequential ChIP results. Nonetheless,
we anticipate that additional experimentation will be required
to clarify these conflicting results.
In summary, we have identified transcription factors THAP11
and ZNF143 as key determinants of HCF-1 recruitment to, and
regulation of, E2F target genes. These findings significantly
change our understanding of the mechanism of HCF-1-medi-
ated gene expression and cell proliferation. Furthermore, these
results suggest that the THAP11/ZNF143/HCF-1 complex is an
important component of the transcriptional regulatory network
controlling cell-cycle progression. Future work will be required
to elucidate the mechanism of THAP11/ZNF143/HCF-1 directed
gene expression and to determine the interplay between this
complex and E2F-associated transcriptional regulatory com-
plexes on cell-cycle control genes.EXPERIMENTAL PROCEDURES
Cell Culture and Cell Synchronization
293T/17, HeLa, SW620, and T98G cells were purchased from ATCC. 293T/17,
HeLa, and SW620 cells were maintained in Dulbecco’s modified Eagle me-
dium (high glucose) supplemented with 10% fetal bovine serum. T98G were
maintained in minimal essential medium supplemented with 10% fetal bovine
serum. All cells were grown at 37C in a humidified cell culture incubator con-
taining 5% CO2.
HeLa cells were enriched at prometaphase using thymidine-nocodazole
block. Cells (30% confluence) were cultured in medium containing 2 mM
thymidine for 18 hr, after which the thymidine-DMEM medium was removed,
and culture dishes were rinsed. Cells were then cultured in DMEM medium
containing 100 ng/ml nocodazole (Sigma) for 13 hr. HeLa cells were subse-
quently harvested for the G2/M population (0 hr) or transferred to normal me-
dium and harvested at indicated time points for flow cytometry, immunoblots,
or ChIP assays.
RBL1 Promoter Construct Stable Transfection
T98G cells containing chromosomally integrated wild-type or E2F binding site
mutant RBL1 promoter constructs were created using phiC31 integrase as
previously described (Hillman and Calos, 2012). Briefly, the luciferase reporter
plasmid pGL4.21 (Promega) was modified to contain an attB phiC31 attach-
ment sequence, creating pGL4.21-attB. An RBL1 promoter fragment (287
to +42) or its tandem E2F binding site mutant (Burkhart et al., 2010) were
cloned into pGL4.21-attB. T98G cells were cotransfected with a codon-
optimized phiC31 expression vector (Raymond and Soriano, 2007) (Addgene
plasmid #13795) and either pGL4.21-attB RBL1-WT or pGL4.21-attButes to Cell Proliferation and Cell-Cycle Progression
F-1/ZNF143 co-occupied E2F-bound genes in HeLa cells expressing either
xperiments. Student’s t test p values are indicated.
cells/well) 4 days posttransduction and viable cells detected using alamarBlue
xperiments.
-1, THAP11, or control (shNS) shRNA.
ells collected 4 days posttransduction with control or two independent HPV18
ight: E7 immunoblot in HeLa cells expressing the indicated shRNA.
posttransduction and analyzed for Annexin V and propidium iodide staining by
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RBL1-E2F mutant plasmids using FugeneHD (Promega) transfection reagent.
Pools of stably transfected cells were selected with 1 mg/ml puromycin. Full
details are available in Supplemental Experimental Procedures.
Retroviral shRNA Transduction and siRNA Transfection
Nonsilencing control, THAP11, and HCF-1 pSuper.Retro.Puro retroviral
shRNA expression vectors have been described previously (Parker et al.,
2012). ZNF143, E2F1, E2F4, DP1, and human papillomavirus type 18
(HPV18) E7 shRNAs were cloned into pSuper.Retro.Puro using the sequences
listed in Supplemental Experimental Procedures. VSV-G pseudotyped retro-
virus was produced and used to spin-infect cells as previously described
(Parker et al., 2012). Two days posttransduction, cells were split into media
containing 2 mg/ml puromycin and selected for at least 2 days or as indicated.
For knockdown using siRNA, HeLa cells were transfected with 30 nM non-
silencing control siRNA (Thermo Scientific) or 15 nM each of THAP11 and
ZNF143 siRNA using Lipofectamine RNAiMAX (Invitrogen) according to the
manufacturer’s instructions. Transfected HeLa cells were harvested for RNA
and protein isolation after 72 hr incubation. THAP11 and ZNF143 siRNA oligo-
nucleotides corresponding to the shRNA targeting sequences were synthe-
sized by Thermo Scientific.
Immunoblots and Quantitative RT-PCR
Whole-cell extracts were prepared from cells expressing shRNA 4 days post-
transduction and immunoblotted as previously described (Parker et al., 2012).
Antibodies andworking dilutions used for immunoblotting are provided in Sup-
plemental Experimental Procedures.
Total RNAwas prepared from shRNA-expressing cells 4 days posttransduc-
tion or from siRNA-transfected cells 3 days posttransfection and analyzed by
quantitative RT-PCR as previously described (Parker et al., 2012).
Immunoprecipitation, ChIP, Sequential ChIP, and ChIP-Western
Nuclear extract preparation and coimmunoprecipitation were performed as
described previously (Parker et al., 2012) with minor modifications. Full details
are provided in Supplemental Experimental Procedures. Immunoprecipitation
was performed using the following antibodies: THAP11 (R&D Systems
#MAB5727, 2 mg) and HCF-1 (Bethyl Laboratories #A301-399A, 1 mg).
ChIP and sequential ChIP (ChIP-reChIP) assays were performed as
described (Parker et al., 2012). Antibodies used for ChIP are as follows:
THAP11 (R&D Systems #MAB5727, 2 mg), HCF-1 (Bethyl Laboratories
#A301-399A, 1 mg), ZNF143 (Proteintech Group #16618-1-AP, 2 mg), E2F1
(Millipore #05-379, 2 mg), E2F3 (Millipore #05-551, 2 mg), E2F4 (Santa Cruz
Biotechnology #A-20x, 2 mg), DP1 (Santa Cruz Biotechnology #sc-610x,
2 mg).
ChIP-Western assays were performed identically as conventional ChIP
except that following the final RIPA wash (50 mM HEPES-KOH [pH 7.6],
500 mM LiCl, 1 mM EDTA, 0.7% Na-Deoxycholate, 1% IGEPAL CA-630)
beads were washed twice with 10 mM Tris-HCl (pH 7.6), 50 mM NaCl, 2 mM
MgCl2, 0.1% Triton X-100 and resuspended in 100 ml of the same buffer.
Where indicated, 1 ml (250 U) of Benzonase nuclease (Sigma) was added
and samples were incubated for 1 hr at 25C in a Thermomixer (Eppendorf)
at 900 rpm. The beads then washed three times with ice-cold RIPA and
once with 10 mM Tris (pH 7.6), 1 mM EDTA, and 50 mM NaCl. Twenty percent
of the bead-bound immunoprecipitated material was reserved for qPCR, and
the remaining 80% was eluted in 2 3 Laemelli sample buffer containing 5%
b-mercaptoethanol at 100C for 5 min. Eluted protein was separated by
SDS-PAGE, transferred to nitrocellulose, and immunoblotted as described
above.
Flow Cytometry
Cell-cycle analysis was determined by flow cytometry using propidium iodide
(PI)-stained cells as described previously (Loomis et al., 2009), with minor
modifications.
Apoptosis was determined by flow cytometry using Annexin V/PI staining
reagents (Invitrogen) according to manufacturer’s instructions. Full details
of flow cytometry procedures are provided in Supplemental Experimental
Procedures.980 Cell Reports 9, 967–982, November 6, 2014 ª2014 The AuthorsIn Silico Analyses
To determine potential THAP11/HCF-1 binding sites colocalized with E2F1,
E2F1-bound loci determined by ENCODE consortium (Consortium, 2011)
were scanned usingMAST software v4.8.1 (Bailey et al., 2009; Bailey andGrib-
skov, 1998) and a previously determined THAP11 DNA motif (Dejosez et al.,
2010).
ChIP-seq data were retrieved from the NCBI Sequence Read Archive and
mapped to the human hg19 genome using bowtie (v1.0.0, http://bowtie-bio.
sourceforge.net). Peaks were called using HOMER (v4.3, http://homer.salk.
edu). Colocalized peaks were defined as those with centers no more than
500 bp apart. To determine chromatin occupancy correlation, tag densities
surrounding colocalized peaks were compared. E2F1-HCF-1 peaks devoid
of THAP11/ZNF143 were defined as E2F1 peaks directly overlapping HCF-1
with no THAP11 or ZNF143 peaks called within 500 bp. Full details are avail-
able in Supplemental Experimental Procedures.
Statistics
Student’s t test and Pearson product-moment correlation coefficients were
calculated using GraphPad Prism version 5.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2014.09.051.
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